Prevalence of fatigue and depression in ALS patients and change over time

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 80, Issue 10, 2009, Pages 1146-1149

  McElhiney, M C ^a   Rabkin, J G ^a,b   Gordon, P H ^c   Goetz, R ^b   Mitsumoto, H ^b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; COMORBIDITY; DEMOGRAPHY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; FATIGUE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PHYSICAL DISABILITY; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE;

EID: 70349684933     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2008.163246     Document Type: Article

References (13)

1. Rabkin JG, Wagner G, Del Bene M. Resilience and distress among amyotrophic lateral sclerosis patients and caregivers. Psychosom Med 2000;62:271-279 (Pubitemid 30194215)
2. Rabkin JG, Albert S, Del Bene M, et al. Prevalence of depressive disorders and change over time in late-stage ALS. Neurology 2005;65:62-67 (Pubitemid 40967777)
3. Ganzini L, Johnson W, McFarland B, et al. Attitudes of patients with amyotrophic lateral sclerosis and their caregivers toward assisted suicide. n Engl J Med 1998;339:967-973
4. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis: subcommittee on motor neuron diseases/amyotrophic lateral sclerosis. J Neurol Sci 1994;124(Suppl):96-107.
5. Krupp L, LaRocca N, Muir-Nash J, et al. The Fatigue Severity Scale. Arch Neurol 1989;46:1121-1123
6. Spitzer R, Kroenke K, Williams J. Validation and utility of a self-report version of PRIME-MD: the PHQ Primary Care Study. JAMA 1999;282:1737-1744 (Pubitemid 29533604)
7. Cederbaum J, Stambler N, Malta E, et al. The ALSFRS-R: A revised ALS Functional Rating Scale that incorporates assessments of respiratory function. J Neurol Sci 1999;169:13-21. (Pubitemid 29502501)
8. Gordon PH. Clinical trial methodology. In: Mitsumoto H, Przedborski S, Gordon P, eds. Amyotrophic lateral sclerosis. New York: Taylor & Francis, 2006:583-603.
9. Kimura F, Fujimura C, Ishida S, et al. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 2006;66:265-267 (Pubitemid 43970171)
10. Gordon PH, Cheung Y. Letter to Editor. Neurology 2006;67:1314-1315
11. Bakshi R, Shaikh Z, Miletich R, et al. Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Sclerosis 2000;6:181-185 (Pubitemid 30392116)
12. Van der Linden G, Chalder T, Hickie I, et al. Fatigue and psychiatric disorder: different or the same? Psychol Med 1999;29:863-868
13. Rabkin JG, Gordon P, McElhiney M, et al. Modafinil treatment of fatigue in patients with ALS: a placebo-controlled study. Muscle Nerve 2009;39:297-303.